Match Document Document Title
6458337 Diagnostic imaging contrast agent with improved in serum relaxivity  
Compounds of the formula when chelated with metals exhibit improved serum relaxivity and are used in magnetic resonance imaging, particularly for imaging the blood pool.
6455052 Enteric coating, comprising alginic acid, for an oral preparation  
A composition for forming an enteric coating on a tablet, capsule or pellet for oral ingestion includes a liquid mixture of alginic acid particles dispersed in an aqueous solution of a binding...
6455026 Use of protein tyrosine phosphatase zeta as a biomolecular target in the treatment and visualization of brain tumors  
The present invention relates to the use of proteins which are differentially expressed in primary brain tumor tissues, as compared to normal brain tissues, as biomolecular targets for brain tumor...
6451545 Monoclonal antibody specific to anti-human fibrin monomer, process for producing the same, hybridomas, and immunoassay method  
Provided are a monoclonal antibody making it possible to detect a native fibrin monomer, which is produced at the initial state of blood coagulation, and soluble fibrin; a hybridoma; and an...
6447747 Process for the preparation of radiopharmaceuticals  
Process for the preparation of radiohalogenated radiopharmaceuticals by an electrophillic substitution, preferably halogenodestannylation reactions, by the reaction of an organometallic substituted...
6436365 Process for therapeutic treatment of proliferative diseases  
The invention relates to a process for therapeutic treatment of proliferative diseases, which is characterized in that first an administration catheter is placed on the site of the lesion, and a...
6429018 Prenatal screening for Down's syndrome using hyperglycosylated gonadotropin  
A prenatal screening method for Down's syndrome involves assaying for hyperglycosylated gonadotropin in biological test samples such as urine, plasma or serum obtained from pregnant women....
6428767 Method for identifying the source of carbon in 1,3-propanediol  
A new polypropylene terephthalate composition is provided. The polypropylene terephthalate is comprised of 1,3-propanediol and terephthalate. The 1,3-propanediol is produced by the bioconversion of...
6416734 Recombinant alpha-fetoprotein for treating and diagnosing cancers  
Disclosed is a method of inhibiting a neoplasm in a mammal, the method includes administering to the mammal a therapeutically effective amount of recombinant human alpha-fetoprotein.
6410509 Use of MHC class II ligands as adjuvant for vaccination and of LAG-3 in cancer treatment  
The present invention concerns the use of a MHC class II ligand, LAG-3, for the manufacture of a medicament for preventing or treating pathological conditions involving an antigen specific immune...
6409987 Targeted agents useful for diagnostic and therapeutic applications  
A selectively targeted agent comprising a dermatan sulfate having more than about 25% repeating L-iduronic acid→4,6-di-O-sulfated N-acetyl-D-galactosamine disaccharide units that is covalently...
6399068 Method of treatment with a non-antigenic toxin-conjugate and fusion protein of internalizing receptor system  
A conjugate of a toxin and a cytokine, and a fusion protein comprising a bispecific antibody that has a first specificity for a cell marker specific to a malignant cell and a second specificity for...
6395256 Adenosine detection in small samples  
The invention relates to a method for detecting adenosine with the inactive S-adenosyl homocysteine hydrolase's enzyme which selectively and only binds adenosine with high affinity. The inventive...
RE37710 Radiometal-binding analogues of luteinizing hormone releasing hormone  
Peptide, derivatives of leutenizing hormone releasing hormone that are capable of binding radionuclides are provided. The peptide derivatives are readily labeled with isotopes of rhenium or...
6391279 Radioactive seeds for brachytherapy and a process for making the same  
Novel radioactive seeds for brachytherapy and a reproducible method of manufacturing the seeds is described, wherein the seeds contain either Pd-103 or I-125 disposed within a cured resin matrix.
6379650 Technetium 99m-N2S2-congo red complexes utilizing diamide dithiolate ligand systems for radioimaging  
The present invention discloses a group of technetium 99m-N 2 S 2 -congo red complexes that utilize diamide dithiolate ligand systems to synthesize compounds for radioimaging. The complexes have...
6375926 Labelled elastase inhibitors  
A human leucocyte elastase (HLE) inhibitor labelled with a detector moiety where the inhibitor is synthetic and has a molecular weight of less than 2000, is useful for the diagnostic imaging of...
6375930 Membrane incorporation of texaphyrins  
Compositions having a texaphyrin-lipophilic molecule conjugate loaded into a biological vesicle and methods for imaging, diagnosis and treatment using the loaded vesicle are provided. For example,...
6372194 MRI contrast media recognizing minor environmental changes  
This relates to a contrast medium containing a complex of a gadolinium (Gd) type contrast agent and a polymer. More particularly, the contrast medium wherein the polymer capable of phase transit in...
6373068 Apparatus and method for preparing radioactive medicines for administration  
An irradiation vessel is made from such material and in such form that it can also be used as administration vessel of a medicine contained therein, this medicine first being irradiated with...
6365128 Monitoring gastrointestinal function to guide care of high risk patients  
A method of guiding the care of a critically ill patient or other high risk patient, said method comprising administering an effective dose of a gastric acid stimulant or suppressant agent and then...
6358491 Somatostatin analogs  
The invention provides novel peptide-based pharmacophores and compounds which bind somatostatin receptors with high affinity and which exhibit improved pharmacokinetic properties over known...
6355444 Carcinoma associated antigen (SK1) monoclonal antibodies against SK1, methods of producing these antibodies and uses therefor  
Carcinoma associated antigen (SK1) and monoclonal antibodies and methods for detecting and ameliorating malignant disease. The monoclonal antibodies are specifically reactive with epitopes present...
6350430 Melanocortin receptor ligands and methods of using same  
The invention provides ligands for melanocortin receptors. For example, the invention provides the melanocortin receptor peptide ligand Ac-Nlc-Gln-His-(p(I)-D-Phe)-Arg-(D-Trp)-Cly-NH 2 , (SEQ ID...
6348184 Radiopharmaceutical compositions and matrices and uses thereof  
Novel radiopharmaceutical compositions comprising, in combination with a pharmaceutically acceptable carrier, a radioactive salt of pyrophosphoric acid. Also provided are novel radiopharmaceutical...
6342201 Complex compounds for diagnosis of vascular diseases  
The present invention concerns novel complexes for use in the diagnosis of vascular diseases, methods of manufacturing such complexes and diagnostic agents containing them. These complexes strongly...
6338835 Radioprotectant for peptides labeled with radioisotope  
A method of ameliorating degradation radiolabeled peptides, especially radiolabeled proteins such as antibodies, by including povidone, also widely known as polyvinylpyrrolidone or PVP, as a...
6337627 System of providing medical treatment  
The invention describes methods for locating a treatment device disposed within a living body by means of magnetic fields that are produced by Barkhausen jumps, principally from amorphous tag wires...
6335028 Implantable particles for urinary incontinence  
The invention encompasses the treatment of urinary incontinence, gastroesophageal reflux disease and the amelioration of skin wrinkles using biocompatible hydrophilic cationic microparticles and a...
6334995 Process for the preparation of technetium-99m diethylene triamine penta-acetic acid diester  
A technetium-99m radiolabelled diethylene triamine pentaacetic acid diester kit and process for its preparation for the diagnosis of renal disorders wherein technetium-99m diethylene triamine...
6334996 Chelators that predominantely form a single stereoisomeric species upon coordination to a metal center  
The labeling of biologically important molecules via a bifunctional chelator can result in the formation of isomers or multiple species, which can have significant impact on the biological...
6333020 Methods for treating AVM's using radio active compositions  
Disclosed are methods for treating AVMs in a mammal by use of a radiation composition.
6331285 Structurally determined cyclic metallo-constructs and applications  
A metallo-construct, which may be a peptide, is provided for use as a biological, therapeutic, diagnostic imaging, or radiotherapeutic agent, and for use in library or combinatorial chemistry...
6331284 P202 is a tumor suppressor  
The present invention relates generally to the fields of cancer therapy and gene therapy. More particularly, the invention demonstrates methods for repressing or preventing transformation and...
6322771 Induction of pharmacological stress with adenosine receptor agonists  
A method is provided employing A 2A adenosine receptor agonists as vasodilators to detect the presence and assess the severity of coronary artery stenosis.
6322770 Indazole vitronectin receptor antagonist pharmaceuticals  
The present invention d ribs novel compounds of the formula: (Q) d --L n --C h , useful for the diagnosis and treatment of cancer, methods of imaging tumors in a patient, and methods of...
6319488 Contrast medium for near infrared diagnosis  
This invention relates to colloidal systems charged with polymethine dyes and having suitable photophysical and pharmacological properties, their use as a contrast medium in fluorescence and...
6314314 Method for locating an internal bleeding site in a human body  
A technique for localizing an internal bleeding site in the human body is provided. The technique entails the injection of radioactively labelled protein or factor used in the clotting process in...
6312679 Dense star polymer conjugates as dyes  
Starburst conjugates which are composed of at least one dendrimer in association with at least one unit of a carried agricultural, pharmaceutical, or other material have been prepared. These...
6303101 Bismuth compounds  
The use in diagnostic imaging, in particular X-ray, MRI, ultrasound and scintigraphy, of contrast agents comprising bismuth clusters and/or organic bismuth compounds, and contrast media containing...
6299857 Cardiovascular and thrombus imaging agents, methods and kits  
The invention provides cardiovascular imaging agents comprising a radionuclide in association with a nucleotide polyphosphate targeting molecule. Methods for using the cardiovascular imaging agents...
6299856 Collagen-based delivery of radioactivity for use in brachytherapy  
Disclosed herein is a method for treating a malignancy in an animal by introducing into the animal a radioactive isotope, or stable element subsequently made radioactive, covalently linked to a...
6299860 Method for viewing diseased tissue located within a body cavity  
Methods are provided for in vivo detection of tissue associated with a disease state in a subject, such as tissue located in a body opening. In the invention method, the subject is administered a...
6296833 Human calcium-sensing receptor in the detection and treatment of cancer  
The present invention is directed to methods for treating cancer patients by administering ligands that bind with specificity to the calcium-sensing receptor. In addition, the invention is directed...
6294151 Isotopic urea tablets  
The present invention provides a tablet containing isotope-labeled urea and an inorganic compound.
6284220 Noninvasive imaging of nucleic acid vectors  
Nucleic acid-imaging compositions and methods for noninvasive imaging of a nucleic acid introduced into somatic tissues of an animal or human are disclosed. The noninvasive imaging enables...
6280703 Simultaneous multimodal measurement of physiological function  
A method of measuring physiological function of a group of body cells, includes the step of selecting a detectable agent capable of absorbing or emitting a measurable electromagnetic emission. The...
6277356 Peptides  
Compounds of formula I ##STR1## wherein M is a cation equivalent and A is Phe or Tyr, in free form or in salt form are useful as radio pharmaceuticals when complexed with a radionuclide.
6274118 Localization and therapy of non-prostatic endocrine cancer with agents directed against prostate specific antigen  
It was discovered that prostate-specific antigen is produced by non-prostatic endocrine cancers. It was further discovered that non-prostatic endocrine cancers with steroid receptors can be...
6270744 Diagnostic agent for angiopathic diseases  
A diagnostic agent for angiopathic diseases containing a monoclonal antibody against human smooth muscle myosin or active fragments of the antibody labeled with a radioactive isotope; a kit...